Inventiva Sa Stock Analysis
| IVEVF Stock | USD 4.44 0.00 0.00% |
Inventiva SA holds a debt-to-equity ratio of 0.265. Inventiva's financial risk is the risk to Inventiva stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
Inventiva's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Inventiva's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Inventiva Pink Sheet's retail investors understand whether an upcoming fall or rise in the market will negatively affect Inventiva's stakeholders.
For many companies, including Inventiva, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Inventiva SA, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Inventiva's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that Inventiva's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Inventiva is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Inventiva to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Inventiva is said to be less leveraged. If creditors hold a majority of Inventiva's assets, the Company is said to be highly leveraged.
Inventiva SA is fairly valued with Real Value of 4.44 and Hype Value of 4.44. The main objective of Inventiva pink sheet analysis is to determine its intrinsic value, which is an estimate of what Inventiva SA is worth, separate from its market price. There are two main types of Inventiva's stock analysis: fundamental analysis and technical analysis.
The Inventiva pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Inventiva's ongoing operational relationships across important fundamental and technical indicators.
Inventiva |
Inventiva Pink Sheet Analysis Notes
About 25.0% of the company shares are held by company insiders. The book value of Inventiva was currently reported as 1.66. The company recorded a loss per share of 1.33. Inventiva SA had not issued any dividends in recent years. Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis , mucopolysaccharidoses , and other diseases. Inventiva S.A. was founded in 2011 and is based in Daix, France. Inventiva is traded on OTC Exchange in the United States.The quote for Inventiva SA is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about Inventiva SA call Frederic Cren at 33 3 80 44 75 00 or check out https://www.inventivapharma.com.Inventiva SA Investment Alerts
| Inventiva SA generated a negative expected return over the last 90 days | |
| The company reported the revenue of 4.19 M. Net Loss for the year was (49.63 M) with profit before overhead, payroll, taxes, and interest of 7.48 M. | |
| Inventiva SA has accumulated about 76.72 M in cash with (47.63 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.82. | |
| Roughly 25.0% of the company shares are held by company insiders |
Inventiva Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 212.41 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Inventiva's market, we take the total number of its shares issued and multiply it by Inventiva's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
Inventiva technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.Inventiva SA Price Movement Analysis
The output start index for this execution was fourty-nine with a total number of output elements of twelve. The Moving Average is predictive technique used to analyze Inventiva SA price data points by creating a series of averages of different subsets of Inventiva entire price series.
Inventiva SA Debt to Cash Allocation
Many companies such as Inventiva, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Inventiva SA has accumulated 8.74 M in total debt with debt to equity ratio (D/E) of 0.27, which may suggest the company is not taking enough advantage from borrowing. Inventiva SA has a current ratio of 4.08, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Inventiva until it has trouble settling it off, either with new capital or with free cash flow. So, Inventiva's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Inventiva SA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Inventiva to invest in growth at high rates of return. When we think about Inventiva's use of debt, we should always consider it together with cash and equity.Inventiva Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Inventiva's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Inventiva, which in turn will lower the firm's financial flexibility.About Inventiva Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Inventiva prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Inventiva shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Inventiva. By using and applying Inventiva Pink Sheet analysis, traders can create a robust methodology for identifying Inventiva entry and exit points for their positions.
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis , mucopolysaccharidoses , and other diseases. Inventiva S.A. was founded in 2011 and is based in Daix, France. Inventiva is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Inventiva to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Center Now
Portfolio CenterAll portfolio management and optimization tools to improve performance of your portfolios |
| All Next | Launch Module |
Complementary Tools for Inventiva Pink Sheet analysis
When running Inventiva's price analysis, check to measure Inventiva's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inventiva is operating at the current time. Most of Inventiva's value examination focuses on studying past and present price action to predict the probability of Inventiva's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inventiva's price. Additionally, you may evaluate how the addition of Inventiva to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |